awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38040150-8180BB0F-C0D1-4D39-BC34-AA17EA594777
Q38040150-8180BB0F-C0D1-4D39-BC34-AA17EA594777
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38040150-8180BB0F-C0D1-4D39-BC34-AA17EA594777
The glory of guidelines and the twilight of reality: controversies and challenges in the prevention and treatment of HIV in children.
P2860
Q38040150-8180BB0F-C0D1-4D39-BC34-AA17EA594777
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38040150-8180BB0F-C0D1-4D39-BC34-AA17EA594777
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
10ce36e1d2f36392cf727268298c7715bf1dc123
P2860
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study.